JHJule Harbig

Jule Harbig

*This is an algorithmically generated author record based on publicly available information.

Jule Harbig has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Bence Sipos

    Institute of Pathology, University of Tuebingen, Tuebingen, Germany

    2 shared publications
  • Florian Heinzmann

    Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany

    2 shared publications
  • Grégory Doré

    Institut Pasteur, Nuclear Organization and Oncogenesis Unit, Department of Cell Biology and Infection, Paris, France

    2 shared publications
  • Hien Dang

    Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

    2 shared publications
  • Lars Zender

    Department of Medical Oncology and Pneumology, University Hospital Tuebingen, Tuebingen, Germany

    2 shared publications
  • Lisa Hoenicke

    Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany

    2 shared publications

Latest Publications

  • Open Access

    Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer

    by Marco Seehawer, Florian Heinzmann, Luana D’aRtista, Jule Harbig, Pierre-François Roux, Lisa Hoenicke, Hien Dang, Sabrina Klotz, Lucas Robinson, Grégory Doré, et al.

    In this Article, the pCaMIN construct consisted of ‘mouse MYC and mouse NrasG12V’ instead of ‘mouse Myc and human NRASG12V; and the pCAMIA construct consisted of ‘mouse Myc and human AKT1’ instead of ‘mouse Myc and Akt1’ this has been corrected online.


  • Top Cited Papers

    Necroptosis microenvironment directs lineage commitment in liver cancer

    by Marco Seehawer, Florian Heinzmann, Luana D’aRtista, Jule Harbig, Pierre-François Roux, Lisa Hoenicke, Hien Dang, Sabrina Klotz, Lucas Robinson, Grégory Doré, et al.

    Primary liver cancer represents a major health problem. It comprises hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), which differ markedly with regards to their morphology, metastatic potential and responses to therapy. However, the regulatory molecules and tissue context that commit transformed hepatic cells towards HCC or ICC are largely unknown. Here we show that the hepatic microenvironment epigenetically shapes lineage commitment in mosaic mouse models of liver tumorigenesis. Whereas a necroptosis-associated hepatic cytokine microenvironment determines ICC outgrowth from oncogenically transformed hepatocytes, hepatocytes containing identical oncogenic drivers give rise to HCC if they are surrounded by apoptotic hepatocytes. Epigenome and transcriptome profiling of mouse HCC and ICC singled out Tbx3 and Prdm5 as major microenvironment-dependent and epigenetically regulated lineage-commitment factors, a function that is conserved in humans. Together, our results provide insight into lineage commitment in liver tumorigenesis, and explain molecularly why common liver-damaging risk factors can lead to either HCC or ICC.